• Study Reveals Key Sequences for Normal Expression of Critical Gene in CMT1A
  • ‘Rare Impact Awards’ Dinner Marks Orphan Drug Act and NORD at 35
  • #ECRD2018 – EU Must Do More for Rare Disease Patients, Eurordis Leaders Say
  • Tumor Suppressor Enzyme May Be Therapeutic Target for CMT4J, Study Suggests
  • Trying Out Physical Therapy with CMT
  • New Method to Assess Nerve Fiber Loss Seen to Accurately Measure CMT1 Disability
  • Researchers Develop New Approach to ID Genetic Contributors for CMT
  • CMT Might Have Given Me Hearing Loss
  • People with Disabilities Strive to Work, Overcome Employment Barriers, Survey Reports
  • Lower Muscle Strength, Balance Impairs CMT Type 2 Patients, Study Finds
  • #ECRD2018 – Patient Access and Collaboration Focus of Eurordis Meeting May 10-12
  • To Tell or Not to Tell? That Is the Question